References
- Abdel-Mogib M. 1999. A lupane triterpenoid from Maerua oblongifolia. Phytochemistry. 51(3):445–448.
- Baas WJ. 1985. Naturally occurring seco-ring-A-triterpenoids and their possible biological significance. Phytochemistry. 24(9):1875–1889.
- El-Moghazy S, Kamel M. 1995. Chemical constituents of stems and leaves of Clematis purpurea var. Hybrida Cultivated in Egypt. Indian J Chem. 34:1111–1113.
- Hadizadeh F, Naaman K, Hosseinzadeh H, Randa K-A. 2003. Kaempferol from Saffron Petals. Iranian J Pharmaceut Res. 2:251–252.
- Hoelder S, Clarke PA, Workman P. 2012. Discovery of small molecule cancer drugs: Successes, challenges and opportunities. Mol Oncol. 6(2):155–176.
- Hu HX, Wang XQ, Zhang H, Zhang Q. 2015. Mechanism and clinical progress of molecular targeted cancer therapy. Yao Xue Xue Bao. 50(10):1232–1239.
- Khan MT, Lampronti I, Martello D, Bianchi N, Jabbar S, Choudhuri MSK, Datta BK, Gambari R. 2002. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol. 21(1):187–192.
- Krishnaveni M, Mirunalini S. 2012. Chemopreventive efficacy of Phyllanthus emblica L. (amla) fruit extract on 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis-a dose-response study . Environ Toxicol Pharmacol. 34(3):801–810.
- Liu X, Zhao M, Wu K, Chai X, Yu H, Tao Z, Wang J. 2012. Immunomodulatory and anticancer activities of phenolics from emblica fruit (Phyllanthus emblica L. Food Chem. 131(2):685–690.
- Mao X, Wu L-F, Guo H-L, Chen W-J, Cui Y-P, Qi Q, Li S, Liang W-Y, Yang G-H, Shao Y-Y, et al. 2016. The genus Phyllanthus: an ethnopharmacological, phytochemical, and pharmacological review. Evid Based Complem Alternat Med. 2016:7584952.
- McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC. 1989. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 111(4):273–279.
- Moiteiro C, Justino F, Tavares R, Marcelo-Curto MJ, Florêncio MH, Nascimento MSJ, Pedro M, Cerqueira F, Pinto MMM. 2001. Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro. J Nat Prod. 64(10):1273–1277.
- Moiteiro C, Manta C, Justino F, Tavares R, Curto MJM, Pedro M, Nascimento MSJ, Pinto M. 2004. Hemisynthetic secofriedelane triterpenes with inhibitory activity against the growth of human tumor cell lines in vitro. J Nat Prod. 67(7):1193–1196.
- Ngamkitidechakul C, Jaijoy K, Hansakul P, Soonthornchareonnon N, Sireeratawong S. 2010. Antitumour effects of Phyllanthus emblica L.: induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother Res. 24(9):1405–1413.
- Nguyen T-A, Duong T-H, Le Pogam P, Beniddir M-A, Nguyen H-H, Nguyen T-P, Do T-M, Nguyen K-P. 2018. Two new triterpenoids from the roots of Phyllanthus emblica. Fitoterapia. 130:140–144.
- Sholichin M, Yamasaki K, Kasai R, Tanaka O. 1980. 13C nuclear magnetic resonance of lupane-type triterpenes, lupeol, betulin and betulinic acid. Chem Pharm Bull. 28(3):1006–1008.
- Vadde R, Radhakrishnan S, Kurundu HEK, Reddivari L, Vanamala JK. 2016. Indian gooseberry (Emblica officinalis Gaertn.) suppresses cell proliferation and induces apoptosis in human colon cancer stem cells independent of p53 status via suppression of c-Myc and cyclin D1. J Funct Foods. 25:267–278.
- Wurdack K, Hoffmann P, Samuel R, Bruijn A, Bank M, Chase M. 2004. Molecular phylogenetic analysis of Phyllanthaceae (Phyllanthoideae pro parte, Euphorbiaceae sensu lato) using plastid RBCL DNA sequences. Am J Bot. 91(11):1882–1900.
- Xia Q, Xiao PG, Wan L, Kong J. 1997. Ethnopharmacology of Phyllanthus emblica L. Zhongguo Zhong Yao Za Zhi. 22(9):515–518.
- Xu M, Zhu H-T, Cheng R-R, Wang D, Yang C-R, Tanaka T, Kouno I, Zhang Y-J. 2016. Antioxidant and hyaluronidase inhibitory activities of diverse phenolics in Phyllanthus emblica. Nat Prod Res. 30(23):2726–2729.
- Yan H, Han LR, Zhang X, Feng JT. 2017. Two new Anti-TMV active chalconoid analogues from the root of Phyllanthus emblica. Nat Prod Res. 31(18):2143–2148.
- Zhang Q, Zhang L, Shang L-X, Shao C, Wu Y. 2008. Studies on the chemical constituents of flowers of Prunus mume. Zhong Yao Cai. 31(11):1666–1668.
- Zhang Y, Nagao T, Tanaka T, Yang C, Okabe H, Kouno I. 2004. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol Pharm Bull. 27(2):251–255. [InsertedFromOnline[pubmedMismatch]]